FOXM1 and breast neoplasm: These results were validated in human breast cell lines and mouse breast tumors, however, to further test this hypothesis, we analyzed TCGA data of BRCA patients (n = 1064) and divided them into two groups (FOXM1_low and FOXM1_high) based on FOXM1 mRNA levels.